Library / regulatory-reference
Croatia: Agency for Medicinal Products and Medical Devices (HALMED)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Agency for Medicinal Products and Medical Devices, known by its Croatian initials HALMED, is Croatia's national regulatory authority for medicines and medical devices.
Croatia's market sits inside the European single market, and the agency works within the European regulatory network while overseeing a market that combines imports with a domestic pharmaceutical industry.
How products enter the market
Medicines require marketing authorization through national or European procedures after evaluation of quality, safety and efficacy, and establishments are licensed and inspected by the agency.
Post-market work includes safety monitoring and recalls within the European alert network, with the agency publishing registers and alerts publicly.
Regional and international role
The agency is an active member of the European regulatory network, contributing to shared scientific work, and its experience is a reference for neighboring Balkan authorities pursuing European alignment.
Its public registers and transparency practice are frequently cited in the region.
Using this profile
The agency publishes regulations, registers and alerts in Croatian, with English material, through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Croatia illustrates the regional-exemplar member state: a European-network agency whose practice neighboring candidate countries watch.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.